Please assess the completion status of the following clinical trial:

Trial Title: Study of a Predictor for Cervix Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* cervix epidermoid cancer or adenocarcinoma : I to IIIB~* treatment by radiochemotherapy~* ECOG ≤ 1~* social and psychological compliance for standard treatment of radiochemotherapy for cervix carcinoma~* patient affiliated to health insurance system~* signed informed consent~Exclusion Criteria :~* contraindication to chemoradiotherapy~* resequable cervical cancer~* para-aortic metastases histologically proven~* inability to perform an abdominal MRI or a PET Scan~* contraindications related to MRI: pacemaker, vascular clip, and all devices incompatible with the electromagnetic field generated by MRI~* unbalanced diabete~* administration of EPO~* transfusion within 3 days before the first biopsy~* creatinine clearance under 60 mL / min;~* ANC \<1500 / mm3 and Platelets \<120,000 / mm3~* neuropathy, diabetes (fasting glucose greater than 140 mg / l) or any other condition that strongly contraindicates concomitant chemotherapy with radiotherapy~* sigmoid diverticulitis, Crohn's disease or systemic disease, collagenose

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- local control 19.8Gy (Type: EXPERIMENTAL): local control at 19.8 Gy, at Day 14

Based on this trial design, predict the completion outcome and termination type (if applicable).